Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships

EMBO Rep. 2003 Jun;4 Spec No(Suppl 1):S43-6. doi: 10.1038/sj.embor.embor858.

Abstract

Twenty-seven years of WHO/TDR experience with public–private partnerships

MeSH terms

  • Humans
  • Ivermectin / therapeutic use
  • Onchocerciasis / drug therapy
  • Orphan Drug Production*
  • Rare Diseases / drug therapy*
  • Rare Diseases / economics
  • Rare Diseases / prevention & control*
  • Research / trends*
  • Research Support as Topic
  • Voluntary Health Agencies*
  • World Health Organization

Substances

  • Ivermectin